- Home
- BHR vs ALEC Comparison
BHR vs ALEC Comparison
Compare BHR & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BHR | ALEC |
|---|---|---|
| Founded | 2013 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.2M | 167.6M |
| IPO Year | 2013 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BHR | ALEC |
|---|---|---|
| Price | $1.94 | $2.72 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $4.83 |
| AVG Volume (30 Days) | 326.9K | ★ 1.6M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | ★ 8.47% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $487,614,000.00 | $21,045,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | N/A | $29.87 |
| P/E Ratio | $31.83 | ★ N/A |
| Revenue Growth | ★ 13.03 | N/A |
| 52 Week Low | $1.88 | $1.09 |
| 52 Week High | $3.19 | $3.40 |
Technical Indicators
Market Signals| Indicator | BHR | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 31.28 | 69.38 |
| Support Level | $1.88 | $1.93 |
| Resistance Level | $2.63 | N/A |
| Average True Range (ATR) | 0.05 | 0.21 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 4.88 | 94.19 |
Price Performance
Historical ComparisonAbout BHR Braemar Hotels & Resorts Inc.
Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury hotels and resorts. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment of the hotel lodging industry. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and, among others.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.